Performance of different criteria for refractory myasthenia gravis-Reference-Cited by-同舟云学术

Performance of different criteria for refractory myasthenia gravis

Published:2020-12-31 Issue:4 Volume:28 Page:1375-1384
ISSN:1351-5101
Container-title:European Journal of Neurology
language:en
Short-container-title:Euro J of Neurology

Author:

Tran Christopher¹,Biswas Aishani¹,Mendoza Meg²,Katzberg Hans¹²,Bril Vera¹²^ORCID,Barnett Carolina¹²³^ORCID

Affiliation:

1. Division of Neurology Department of Medicine University of Toronto Toronto Ontario Canada

2. Division of Neurology Department of Medicine The Ellen and Prosserman Centre for Neuromuscular Diseases University Health Network Toronto Ontario Canada

3. Dalla Lana School of Public Health Institute of Health Policy, Management and EvaluationUniversity of Toronto Toronto Ontario Canada

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ene.14675

Reference23 articles.

1. Lifetime course of myasthenia gravis

2. Myasthenic crisis demanding mechanical ventilation

3. Myasthenia gravis: subgroup classification and therapeutic strategies

4. Clinical characteristics of refractory myasthenia gravis patients;Suh J;Yale J Biol Med,2013

5. Refractory myasthenia gravis – Clinical profile, comorbidities and response to rituximab;Sudulagunta SR;Ger Med Sci,2016

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic challenges and unmet needs in the management of myasthenia gravis: an Italian expert opinion;Neurological Sciences;2024-07-05

2. Therapeutic Responses to Efgartigimod for Generalized Myasthenia Gravis in Japan;Neurology Clinical Practice;2024-06

3. Clinical characteristics and outcome of treatment-refractory myasthenia gravis -a retrospective study;2024-05-29

4. Diagnostic value of antibody concentration ratio for treatment-refractory myasthenia gravis;Neurological Sciences;2024-05-23

5. B-cell immune dysregulation with low soluble CD22 levels in refractory seronegative myasthenia gravis;Frontiers in Immunology;2024-04-22